Microrna In Disease Regulation

46 researchers across 5 institutions

46 Researchers
5 Institutions
5 Grant PIs
9 High Impact

Research in this area investigates the role of microRNAs (miRNAs) in regulating biological processes and their implications in various diseases. Scientists examine how these small RNA molecules function as key regulators of gene expression, influencing cellular pathways involved in development, differentiation, and disease pathogenesis. Studies employ molecular biology techniques, bioinformatics, and advanced imaging to identify and characterize specific miRNAs associated with conditions such as cancer, cardiovascular disease, and neurological disorders. Investigations also explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets.

This work holds significant relevance for Arkansas by addressing public health challenges and supporting the state's growing biosciences sector. Understanding miRNA dysregulation in diseases prevalent in the region, like certain cancers and metabolic disorders, can inform the development of new diagnostic tools and treatment strategies. Furthermore, research into environmental exposures and their impact on miRNA expression contributes to understanding potential health risks and safeguarding public well-being.

This field draws on expertise from molecular biology, genetics, bioinformatics, and toxicology. The research is conducted across multiple institutions in Arkansas, fostering collaboration and leveraging diverse strengths in experimental design and data analysis. Connections are made to related areas including cancer mechanisms, epigenetics, and pharmacological studies.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Igor P. Pogribny NCTR 76 18,238 ARA High Impact
Volodymyr Tryndyak NCTR 44 7,008 High Impact
Xinyu Li University of Arkansas 43 5,893 High Impact
Gang� Li UAMS 38 5,080 High Impact
Zhiqiang Qin UAMS 35 3,809 Faculty Grant PI High Impact
Gohar Azhar UAMS 33 3,220 High Impact
Beverly D. Lyn‐Cook NCTR 30 3,206 High Impact
Wei Zhao UA Little Rock 30 3,154 Faculty
Tyrone A. Washington University of Arkansas 27 2,190 Faculty Grant PI High Impact
George Hammons NCTR 24 2,057
Ryan M. Allen UAMS 20 2,301 Faculty Grant PI High Impact
Dongying Li NCTR 20 1,228
Donghoon Yoon UAMS 18 1,272 Faculty
Patricia Porter‐Gill UAMS 18 2,038
Ruofei Du UAMS 16 826 Faculty
Svitlana Shpyleva NCTR 16 1,449
Neha S. Dole UAMS 14 634 Faculty Grant PI
Ana Clara P. Azevedo‐Pouly UAMS 13 790
Shan Zhao University of Arkansas 13 790
Hoda A. Hagrass UAMS 12 510 Faculty

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
2 works in 2028
-59.1% CAGR 2018–2028
Leadership concentration
6.5% held by global top 5 institutions
Fragmented HHI 32
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2028 window.

Top US institutions in this area

  1. 1 Harvard University 2,559
  2. 2 The University of Texas MD Anderson Cancer Center 1,710
  3. 3 The Ohio State University 1,371
  4. 4 National Institutes of Health 1,185
  5. 5 Johns Hopkins University 1,166

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Microrna In Disease Regulation.

49%
Shelby Johns University of Arkansas
39%
Xinyu Li University of Arkansas
39%
Carly Orr Ouachita Baptist University
38%
Pieter Jan Koopmans University of Arkansas
Tao Han NCTR
36%
Philip H. Williams UA Little Rock
36%
Pieter Jan Koopmans University of Arkansas
35%
Philip H. Williams UA Little Rock

Researchers with Federal Grants

Browse All 46 Researchers in Directory